CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-20 | Silver Brian M. Chief Financial Officer | Purchase | +1,000 | $15.00 | $15K | 1,000 |
| 2021-07-15 | Silver Brian M. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +250,441 | 250,441 | ||
| 2021-07-15 | Gruia Gabriela Director | Grant or award · Stock Option (right to buy) | +9,146 | 9,146 | ||
| 2021-07-15 | Gruia Gabriela Director | Grant or award · Stock Option (right to buy) | +9,146 | 9,146 |
Page 8 of 8 · 144 trades